Phreesia/$PHR
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Phreesia
Phreesia Inc is a provides an integrated software, payments, and engagement platform designed to address three foundational challenges in healthcare delivery: access to care, affordability of care, and patient health outcomes. Its platform is embedded directly into provider workflows and patient interactions, enabling healthcare organizations to activate patients, streamline administrative processes, and improve financial performance across the care continuum. The group serves a diverse group of healthcare organizations, including ambulatory practices, health systems, and hospitals, as well as life sciences companies, government entities, patient advocacy, public interest, and not-for-profit and other organizations.
Ticker
$PHR
Sector
Primary listing
NYSE
Employees
1,789
Headquarters
Website
Phreesia Metrics
BasicAdvanced
$588m
250.51
$0.04
0.86
-
Price and volume
Market cap
$588m
Beta
0.86
52-week high
$32.76
52-week low
$7.77
Average daily volume
2.3m
Financial strength
Current ratio
1.527
Quick ratio
1.238
Long term debt to equity
27.646
Total debt to equity
30.382
Interest coverage (TTM)
0.38%
Profitability
EBITDA (TTM)
34.064
Gross margin (TTM)
67.93%
Net profit margin (TTM)
0.48%
Operating margin (TTM)
0.54%
Effective tax rate (TTM)
125.79%
Revenue per employee (TTM)
$270,000
Management effectiveness
Return on assets (TTM)
0.31%
Return on equity (TTM)
0.77%
Valuation
Price to earnings (TTM)
250.512
Price to revenue (TTM)
1.202
Price to book
1.74
Price to tangible book (TTM)
17.72
Price to free cash flow (TTM)
10.616
Free cash flow yield (TTM)
9.42%
Free cash flow per share (TTM)
0.911
Growth
Revenue change (TTM)
14.48%
Earnings per share change (TTM)
-103.80%
3-year revenue growth (CAGR)
19.60%
3-year earnings per share growth (CAGR)
-77.43%
What the Analysts think about Phreesia
Analyst ratings (Buy, Hold, Sell) for Phreesia stock.
Phreesia Financial Performance
Revenues and expenses
Phreesia Earnings Performance
Company profitability
Phreesia News
AllArticlesVideos
Phreesia Sets Release Date for Fiscal First Quarter 2027 Results
Business Wire·5 days ago
Rosen Law Firm Encourages Phreesia, Inc. Investors to Inquire About Securities Class Action Investigation – PHR
Business Wire·3 weeks ago
Phreesia Named to Becker's Hospital Review's 2026 List of “Revenue Cycle Management Companies to Know”
Business Wire·3 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Phreesia stock?
Phreesia (PHR) has a market cap of $588M as of May 06, 2026.
What is the P/E ratio for Phreesia stock?
The price to earnings (P/E) ratio for Phreesia (PHR) stock is 250.51 as of May 06, 2026.
Does Phreesia stock pay dividends?
No, Phreesia (PHR) stock does not pay dividends to its shareholders as of May 06, 2026.
When is the next Phreesia dividend payment date?
Phreesia (PHR) stock does not pay dividends to its shareholders.
What is the beta indicator for Phreesia?
Phreesia (PHR) has a beta rating of 0.86. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.